litlas
ログインアカウント作成

Mauro Schechter

1994–2025 年に発表

54
論文数
20,004
被引用数
50
h 指数
51
i10 指数

被引用数

Mauro Schechter の年別被引用数1988 年: 被引用 2 件1995 年: 被引用 2 件1996 年: 被引用 1 件1997 年: 被引用 3 件1998 年: 被引用 2 件1999 年: 被引用 3 件2000 年: 被引用 33 件2001 年: 被引用 46 件2002 年: 被引用 54 件2003 年: 被引用 80 件2004 年: 被引用 82 件2005 年: 被引用 54 件2006 年: 被引用 81 件2007 年: 被引用 99 件2008 年: 被引用 180 件2009 年: 被引用 146 件2010 年: 被引用 149 件2011 年: 被引用 175 件2012 年: 被引用 161 件2013 年: 被引用 160 件2014 年: 被引用 174 件2015 年: 被引用 183 件2016 年: 被引用 202 件2017 年: 被引用 149 件2018 年: 被引用 156 件2019 年: 被引用 666 件2020 年: 被引用 516 件2021 年: 被引用 392 件2022 年: 被引用 276 件2023 年: 被引用 184 件2024 年: 被引用 345 件2025 年: 被引用 115 件2026 年: 被引用 2 件1989〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,613 件、この内訳の 32.8%イギリス: 引用元論文 586 件、この内訳の 7.4%南アフリカ: 引用元論文 454 件、この内訳の 5.7%カナダ: 引用元論文 319 件、この内訳の 4%フランス: 引用元論文 266 件、この内訳の 3.3%スイス: 引用元論文 238 件、この内訳の 3%オーストラリア: 引用元論文 205 件、この内訳の 2.6%ウガンダ: 引用元論文 189 件、この内訳の 2.4%オランダ: 引用元論文 185 件、この内訳の 2.3%ブラジル: 引用元論文 183 件、この内訳の 2.3%スペイン: 引用元論文 182 件、この内訳の 2.3%中国: 引用元論文 180 件、この内訳の 2.3%
0%32.8%その他 29.6%

機関

分野

  • Medicine74.9%
  • Immunology and Microbiology16%
  • Biochemistry, Genetics and Molecular Biology2.6%
  • Health Professions1.5%
  • Psychology1.5%
  • Social Sciences1.4%
  • その他2.1%

トピック

  • HIV/AIDS Research and Interventions22.8%
  • HIV Research and Treatment12.2%
  • HIV/AIDS drug development and treatment10.8%
  • HIV, Drug Use, Sexual Risk7.9%
  • HIV-related health complications and treatments5.8%
  • Sex work and related issues4.5%
  • その他36%

共著者

全論文

検索で開く
  1. Mpox in people with advanced HIV infection: a global case series

    著者: Oriol Mitjà, Andrea Alemany, Michael Marks, Jezer I Lezama Mora, Juan Carlos Rodríguez‐Aldama, Mayara Secco Torres Silva, Ever Arturo Corral Herrera, Brenda Crabtree‐Ramírez, José Luís Blanco, Nicolò Girometti, Valentina Mazzotta, Aniruddha Hazra, Macarena Silva, Juan José Montenegro-Idrogo, Kelly A. Gebo, Jade Ghosn, María Fernanda Peña Vázquez, Eduardo Matos Prado, Uche Unigwe, Judit Villar-García, Noah Wald‐Dickler, Jason Zucker, Roger Paredes, Alexandra Calmy, Laura Waters, Cristina Galván‐Casas, Sharon Walmsley, Chloe Orkin, Viviana Leiro, Lucila Marchetta, Patricia Fernández Pardal, María Inés Figueroa, Pedro Cahn, Katharina Grabmeier‐Pfistershammer, Agnès Libois, Laurens Liesenborghs, Beatriz Grinsztejn, Mauro Schechter, Alberto dos Santos de Lemos, Alvaro Furtado Costa, Simone Queiroz Rocha, José Valdez Madruga, Darrell H. S. Tan, Sharmistha Mishra, Shreya Shah, Camila Jorquera, Alberto Castillo, Mauricio Carrión, Nelson Cevallos, Romain Palich, Valérie Pourcher, Emma Rubenstein, Pascal Migaud, Christoph Boesecke, Christian Hoffmann, Konstantinos Protopapas, Silvia Nozza, Anna Maria Cattelan, Cristina Mussini, Antonella d’Arminio Monforte, Raúl Adrian Cruz Flores, Edgar Pérez‐Barragán, Alma Leticia Rodríguez Guzmán, Dimie Ogoina, Nneka Marian Chika-Igwenyi, Onyeaghala Chizaram, Jenny Valverde López, Angelica García Tello, María Ubals, Martí Vall, Adrià Mendoza, Clara Suñer, Bonaventura Clotet, Jordi Bechini, José Antonio Lepe, Ma Dolores Navarro-Amuedo, José I Bernadino, Alba Català, Eloy José Tarín Vicente, Borja González Rodríguez, Sergi Rodríguez-Mercader, Francisca Sánchez-Martinez, Esperanza Cañas‐Ruano, Laura Parra‐Navarro, Finn Filén, Carmen Tallón de Lara, Dominique L. Braun, Vanja Piezzi, Michael Burkhard, Helen Kovari, Anja Mönch, Jake Dunning, Pedro Simoes, Achyuta Nori, Sarah S. Keegan, John Thornhill, Vanessa Apea, Teymur Noori, Joyce Jones, Seth D. Judson ほか 9 名 - The Lancet 2023 被引用: 485

  2. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

    著者: Robert M. Grant, Javier R. Lama, Peter L. Anderson, Vanessa McMahan, Albert Liu, Lorena Vargas, Pedro Goicochea, Martín Casapía, Juan V. Guanira, Maria Esther Ramirez-Cardich, Orlando Montoya-Herrera, Telmo Fernández, Valdiléa G. Veloso, Susan Buchbinder, Suwat Chariyalertsak, Mauro Schechter, Linda‐Gail Bekker, Kenneth H. Mayer, Esper G. Kallás, K. Rivet Amico, Kathleen Mulligan, Lane R. Bushman, Robert Hance, Carmela Ganoza, Patricia Defechereux, Brian S. Postle, Furong Wang, J. Jeff McConnell, Jia‐Hua Zheng, Jeanny Lee, James F. Rooney, Howard S. Jaffe, Ana I. Martínez, David Burns, David V. Glidden - New England Journal of Medicine 2010 被引用: 5,133

  3. Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society—Lancet Commission

    著者: Linda‐Gail Bekker, George A.O. Alleyne, Stefan Baral, Javier Cepeda, Demetre Daskalakis, David W. Dowdy, Mark Dybul, Serge Eholié, Kene Esom, Geoff P. Garnett, Anna Grimsrud, James Hakim, Diane V. Havlir, Michael Isbell, Leigh F. Johnson, Adeeba Kamarulzaman, Parastu Kasaie, Michel D. Kazatchkine, Nduku Kilonzo, Michael J. Klag, Marina B. Klein, Sharon R. Lewin, Chewe Luo, Keletso Makofane, Natasha K. Martin, Kenneth H. Mayer, Gregorio A. Millett, Ntobeko Ntusi, Loyce Pace, Carey Pike, Peter Piot, Anton Pozniak, Thomas C. Quinn, Jürgen K. Rockstroh, Jirair Ratevosian, Owen Ryan, Serra Sippel, Bruno Spire, Agnès Soucat, Ann Starrs, Steffanie A. Strathdee, Nicholas M. Thomson, Stefano Vella, Mauro Schechter, Peter Vickerman, Brian W. Weir, Chris Beyrer - The Lancet 2018 被引用: 761

  4. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study

    著者: Robert M. Grant, Peter L. Anderson, Vanessa McMahan, Albert Liu, K. Rivet Amico, Megha Mehrotra, Sybil Hosek, Carlos Mosquera, Martín Casapía, Orlando Montoya, Susan Buchbinder, Valdiléa G. Veloso, Kenneth H. Mayer, Suwat Chariyalertsak, Linda‐Gail Bekker, Esper G. Kallás, Mauro Schechter, Juan V. Guanira, Lane R. Bushman, David Burns, James F. Rooney, David V. Glidden - The Lancet Infectious Diseases 2014 被引用: 1,250

  5. Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men

    著者: Peter L. Anderson, David V. Glidden, Albert Liu, Susan Buchbinder, Javier R. Lama, Juan V. Guanira, Vanessa McMahan, Lane R. Bushman, Martín Casapía, Orlando Montoya-Herrera, Valdiléa G. Veloso, Kenneth H. Mayer, Suwat Chariyalertsak, Mauro Schechter, Linda‐Gail Bekker, Esper G. Kallás, Robert M. Grant, For the iPrEx Study Team - Science Translational Medicine 2012 被引用: 1,043

  6. HIV-1 DNA predicts disease progression and post-treatment virological control

    著者: James P. Williams, Jacob Hurst, Wolfgang Stöhr, Nicola Robinson, Helen Brown, Martin Fisher, Sabine Kinloch, David A. Cooper, Mauro Schechter, Giuseppe Tambussi, Sarah Fidler, Mary Carrington, Abdel Babiker, Jonathan Weber, Kersten K. Koelsch, Anthony D. Kelleher, Rodney E. Phillips, John Frater, on behalf of the SPARTAC trial investigators - eLife 2014 被引用: 307

  7. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs

    著者: Frederick L. Altice, Adeeba Kamarulzaman, Vincent Soriano, Mauro Schechter, Gerald Friedland - The Lancet 2010 被引用: 507

  8. Modeling the Slow CD4+ T Cell Decline in HIV-Infected Individuals

    著者: Sunpeng Wang, Patricia Hottz, Mauro Schechter, Libin Rong - PLoS Computational Biology, PLoS Comput. Biol. 2015 被引用: 72

  9. Immunological biomarkers predict HIV-1 viral rebound after treatment interruption

    著者: Jacob Hurst, Matthias Hoffmann, Matthew Pace, James P. Williams, John Thornhill, Elizabeth Hamlyn, Jodi Meyerowitz, Chris Willberg, Kersten K. Koelsch, Nicola Robinson, Helen Brown, Martin Fisher, Sabine Kinloch, David A. Cooper, Mauro Schechter, Giuseppe Tambussi, Sarah Fidler, Abdel Babiker, Jonathan Weber, Anthony D. Kelleher, Rodney E. Phillips, John Frater - Nature Communications 2015 被引用: 178

  10. International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials

    著者: T. Christopher Mast, Lisa Kierstead, Swati B. Gupta, Alexander Nikas, Esper G. Kallás, Vladimir Novitsky, Bernard Mbewe, Punee Pitisuttithum, Mauro Schechter, Eftyhia Vardas, Nathan Wolfe, Miguel Aste-Amézaga, Danilo R. Casimiro, Paul Coplan, Walter L. Straus, John W. Shiver - Vaccine 2009 被引用: 276

  11. Community-Based Interventions to Improve and Sustain Antiretroviral Therapy Adherence, Retention in HIV Care and Clinical Outcomes in Low- and Middle-Income Countries for Achieving the UNAIDS 90-90-90 Targets

    著者: Jean B. Nachega, Olatunji Adetokunboh, Olalekan A. Uthman, Amy W. Knowlton, Frederick L. Altice, Mauro Schechter, Omar Galárraga, Elvin Geng, Karl Peltzer, Larry W. Chang, Gilles Van Cutsem, Shabbar Jaffar, Nathan Ford, Claude A. Mellins, Robert H. Remien, Edward J. Mills - Current HIV/AIDS Reports 2016 被引用: 185

  12. Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil

    著者: Ricardo Sobhie Diaz, James Hunter, Michelle Camargo, Danilo Dias, Juliana Galinskas, Isabela Nassar, Isaac Barbosa de Lima, Débora Bellini Caldeira, Maria Cecília Araripe Sucupira, Mauro Schechter - BMC Infectious Diseases 2023 被引用: 34

  13. HIV-Related Stigma, Isolation, Discrimination, and Serostatus Disclosure

    著者: Jean B. Nachega, Chelsea Morroni, José M Zuniga, Renslow Sherer, Chris Beyrer, Suniti Solomon, Mauro Schechter, Jürgen K. Rockstroh - Journal of the International Association of Physicians in AIDS Care 2012 被引用: 161

  14. Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial

    著者: Kathleen Mulligan, David V. Glidden, Peter L. Anderson, Albert Liu, Vanessa McMahan, Pedro Gonzáles, Maria Esther Ramirez-Cardich, Sirianong Namwongprom, Piotr Chodacki, Laura Maria Carvalo de Mendonca, Furong Wang, Javier R. Lama, Suwat Chariyalertsak, Juan V. Guanira, Susan Buchbinder, Linda‐Gail Bekker, Mauro Schechter, Valdiléa G. Veloso, Robert M. Grant - Clinical Infectious Diseases 2015 被引用: 150

  15. Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme

    著者: Catherine C. McGowan, Pedro Cahn, Eduardo Gotuzzo, Denis Padgett, Jean W. Pape, Marcelo Wolff, Mauro Schechter, Daniel R. Masys - International Journal of Epidemiology 2007 被引用: 141

  16. Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial

    著者: Jason V. Baker, Shweta Sharma, Birgit Grund, Adam Rupert, Julia A. Metcalf, Mauro Schechter, Paula Munderi, Inka Aho, Sean Emery, Abdel Babiker, Andrew Phillips, Jens Lundgren, James D. Neaton, H. Clifford Lane, INSIGHT START (Strategic Timing of AntiRetroviral Treatment) Study Group - Open Forum Infectious Diseases 2017 被引用: 87

  17. Metabolic Effects of Preexposure Prophylaxis With Coformulated Tenofovir Disoproxil Fumarate and Emtricitabine

    著者: David V. Glidden, Kathleen Mulligan, Vanessa McMahan, Peter L. Anderson, Juan V. Guanira, Suwat Chariyalertsak, Susan Buchbinder, Linda‐Gail Bekker, Mauro Schechter, Beatriz Grinsztejn, Robert M. Grant - Clinical Infectious Diseases 2018 被引用: 77

  18. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

    著者: Paula Braitstein, Martin W G Brinkhof, François Dabis, Mauro Schechter, Andrew Boulle, Paolo Miotti, Robin Wood, Christian Laurent, Eduardo Sprinz, Catherine Seyler, David R Bangsberg, Eric Balestre, Jonathan A C Sterne, Margaret May, Matthias Egger - The Lancet 2006 被引用: 1,107

  19. Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population

    著者: Alison Rodger, Rebecca Lodwick, Mauro Schechter, Steven G. Deeks, Janaki Amin, Richard Gilson, Roger Paredes, Elżbieta Bąkowska, Frederik Neess Engsig, Andrew Phillips - AIDS 2012 被引用: 371

  20. Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy

    著者: Wolfgang Stöhr, Sarah Fidler, Myra O. McClure, Jonathan Weber, David A. Cooper, Gita Ramjee, Pontiano Kaleebu, Giuseppe Tambussi, Mauro Schechter, Abdel Babiker, Rodney E. Phillips, Kholoud Porter, John Frater - PLoS ONE 2013 被引用: 93

  21. Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

    著者: David A. Cooper, Roy T. Steigbigel, José M. Gatell, Jürgen K. Rockstroh, Christine Katlama, Patrick Yéni, Adriano Lazzarin, Bonaventura Clotet, Princy Kumar, Joseph Eron, Mauro Schechter, Martin Markowitz, Mona Loutfy, Jeffrey L. Lennox, Jing Zhao, Joshua Chen, Desmon̄d Ryan, Rand R. Rhodes, John A. Killar, Lucinda R. Gilde, Kim M. Strohmaier, Anne R. Meibohm, Michael D. Miller, Daria J. Hazuda, Michael L. Nessly, Mark J. DiNubile, Robin Isaacs, Hedy Teppler, Bach-Yen Nguyen - New England Journal of Medicine 2008 被引用: 507

  22. Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral- Therapy-Naive Patients Infected with HIV-1

    著者: Frank van Leth, Prahpan Phanuphak, Erik S.G. Stroes, Brian Gazzard, Pedro Cahn, François Raffi, Robin Wood, Mark Bloch, Christine Katlama, John J.P. Kastelein, Mauro Schechter, Robert L Murphy, Andrzej Horban, David B. Hall, Joep M. A. Lange, Peter Reiss - PLoS Medicine 2004 被引用: 276

  23. Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis

    著者: Marc Solomon, Javier R. Lama, David V. Glidden, Kathleen Mulligan, Vanessa McMahan, Albert Liu, Juan V. Guanira, Valdiléa G. Veloso, Kenneth H. Mayer, Suwat Chariyalertsak, Mauro Schechter, Linda‐Gail Bekker, Esper G. Kallás, David Burns, Robert M. Grant - AIDS 2014 被引用: 142

  24. Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities

    著者: Jean B. Nachega, Edward J. Mills, Mauro Schechter - Current Opinion in HIV and AIDS 2009 被引用: 139